Abe O - Search Results

1

Phase II study of KRN8602, 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin hydrochloride, MX2 x HCl in patients with metastatic breast cancer.

Katsumata N, Watanabe T, Tominaga T, Ogawa M, Adachi I, Enomoto K, Kajiwara T, Kusama M, Yamada Y, Abe O. Katsumata N, et al. Among authors: abe o. Cancer Chemother Pharmacol. 1999;43(6):441-4. doi: 10.1007/s002800050921. Cancer Chemother Pharmacol. 1999. PMID: 10321502 Clinical Trial.

2

[Phase I study of NK 622 (toremifene citrate)].

Tominaga T, Hayashi K, Hayasaka A, Asaishi K, Abe R, Kimishima I, Izuo M, Iino Y, Yokoe T, Abe O, et al. Tominaga T, et al. Among authors: abe r, abe o. Gan To Kagaku Ryoho. 1992 Dec;19(14):2363-72. Gan To Kagaku Ryoho. 1992. PMID: 1463343 Clinical Trial. Japanese.

3

Appraisal of adjuvant chemoendocrine therapy with tamoxifen plus tegafur in patients with breast cancer.

Enomoto K, Fujiwara K, Ikeda T, Katoh S, Abe O. Enomoto K, et al. Among authors: abe o. Keio J Med. 1991 Sep;40(3):123-8. doi: 10.2302/kjm.40.123. Keio J Med. 1991. PMID: 1753554 Free article. Clinical Trial.

4

[Changes in future prospect in the management of breast cancer with special reference to BHENO- and GENO-type typic expression].

Abe O, Enomoto K, Ueda M, Kikuchi K, Fujiwara K. Abe O, et al. Gan To Kagaku Ryoho. 1991 Jul;18(9):1395-402. Gan To Kagaku Ryoho. 1991. PMID: 1854209 Japanese. No abstract available.

5

Japanese early phase II study of droloxifene in the treatment of advanced breast cancer. Preliminary dose-finding study.

Abe O. Abe O. Am J Clin Oncol. 1991;14 Suppl 2:S40-5. doi: 10.1097/00000421-199112002-00009. Am J Clin Oncol. 1991. PMID: 1962596 Clinical Trial.

6

Endothelin-1 inhibits adipogenic differentiation of 3T3-L1 preadipocytes.

Tanahashi T, Yamaguchi K, Ishikawa S, Kusuhara M, Adachi I, Abe O. Tanahashi T, et al. Among authors: abe o. Biochem Biophys Res Commun. 1991 Jun 14;177(2):854-60. doi: 10.1016/0006-291x(91)91868-d. Biochem Biophys Res Commun. 1991. PMID: 2049106

7

A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer.

Izuo M, Yoshida M, Tominaga T, Abe O, Enomoto K, Nomura Y, Kubo K, Takatani O. Izuo M, et al. Among authors: abe o. Cancer. 1985 Dec 1;56(11):2576-9. doi: 10.1002/1097-0142(19851201)56:11<2576::aid-cncr2820561107>3.0.co;2-i. Cancer. 1985. PMID: 2932213 Clinical Trial.

8

[Cell cycle effects of antiestrogens and medroxyprogesterone acetate on the MCF-7 human breast cancer cell line].

Ikeda T, Enomoto K, Fujiwara K, Koh J, Ishii S, Fukutomi T, Nakamura A, Abe O, Tsuru S, Jinnaka H. Ikeda T, et al. Among authors: abe o. Nihon Gan Chiryo Gakkai Shi. 1985 Dec 20;20(10):2243-50. Nihon Gan Chiryo Gakkai Shi. 1985. PMID: 2937861 Japanese. No abstract available.

9

Mode of action of estra-1,3,5(10)-triene-3,17 beta-diol 3-benzoate 17-[4-(4-bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)acet ate) on human breast carcinoma xenografts in nude mice.

Kubota T, Koh J, Yamada Y, Oka S, Enomoto K, Ishibiki K, Abe O, Masui O, Asano K. Kubota T, et al. Among authors: abe o. Jpn J Cancer Res. 1988 Nov;79(11):1224-9. doi: 10.1111/j.1349-7006.1988.tb01548.x. Jpn J Cancer Res. 1988. PMID: 3147278 Free PMC article.

10

[Clinical investigation of oral high-dose medroxyprogesterone acetate (MPA) in advanced breast cancer--double-blind controlled study: Japanese Group for MPA Treatment of Breast Cancer].

Izuo M, Tominaga T, Yoshida M, Nomura Y, Abe O, Enomoto K, Kubo K, Takatani O. Izuo M, et al. Among authors: abe o. Gan No Rinsho. 1985 May;31(5):487-93. Gan No Rinsho. 1985. PMID: 3160869 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

877 results

Search Page

Filters